Clinical Trials
15 trialsNCT01042379 2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
NCT03678883 2026-04-03
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Phase 2 Active not recruiting
NCT00248287 2025-01-29
CA225200
US Oncology Research
Phase 2 Active not recruiting
NCT02030678 2018-09-05
A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT03562390 2018-06-19
Irinotecan for Advanced and Metastatic Breast Cancer
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT00617539 2018-04-20
Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
University of California, San Francisco
Phase 2 Completed
NCT00303992 2018-01-17
Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
University of California, San Francisco
Phase 2 Completed
NCT00079118 2016-12-13
Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00275041 2016-12-13
Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00003351 2016-07-14
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01173497 2016-03-17
A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Sanofi
Phase 2 Completed
NCT00693719 2015-11-20
Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
University of Arizona
Phase 2 Completed
NCT00476827 2013-07-17
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Duke University
Phase 2 Terminated
NCT00004182 2012-06-06
Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
Northwestern University
Phase 2 Completed
NCT00072852 2008-10-16
Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine
Pfizer
Phase 2 Completed